Demystifying EIC Accelerator Technology Readiness Levels in Pharmaceuticals: From Concept to Market

TRLs in Pharmaceutical Development: A Detailed Walkthrough

In the realm of pharmaceuticals, Technology Readiness Levels (TRLs) serve as a critical pathway from initial research to the marketing of a new drug. Each level represents a significant step in the journey of drug development. Below is a detailed explanation of each TRL in the context of pharmaceuticals.

  1. TRL1 – Findings Reviewed: This initial stage involves reviewing existing research and findings, laying the groundwork for new pharmaceutical developments.
  2. TRL2 – Research Idea: At this stage, researchers formulate a specific research idea or hypothesis based on the initial findings.
  3. TRL3 – Design Proof of Concept: Scientists design experiments to prove the concept of the proposed pharmaceutical treatment.
  4. TRL4 – Demonstrate Proof of Concept: The proof of concept is demonstrated through initial laboratory experiments, validating the research idea.
  5. TRL5 – Pilot Drug Produced: A pilot version of the drug is produced, typically in small quantities, for preliminary testing.
  6. TRL6 – Phase 1 Clinical Trials: The drug enters Phase 1 clinical trials, where it is tested on a small group of people to evaluate its safety, determine a safe dosage range, and identify side effects.
  7. TRL7 – Phase 2 Clinical Trials: In Phase 2 trials, the drug is given to a larger group of people to see if it is effective and to further evaluate its safety.
  8. TRL8 – New Drug Registration: After successful clinical trials, the drug goes through the process of registration, where it is thoroughly reviewed and approved by regulatory authorities for market release.
  9. TRL9 – Drug Distributed and Marketed: The final stage where the drug is fully approved, manufactured on a large scale, distributed, and marketed to the public.

Pharmaceutical TRLs

The progression of pharmaceuticals from TRL1 to TRL9 is a complex journey from theoretical research to a marketable drug.

About

The articles found on Rasph.com reflect the opinions of Rasph or its respective authors and in no way reflect opinions held by the European Commission (EC) or the European Innovation Council (EIC). The provided information aims to share perspectives that are valuable and can potentially inform applicants regarding grant funding schemes such as the EIC Accelerator, EIC Pathfinder, EIC Transition or related programs such as Innovate UK in the United Kingdom or the Small Business Innovation and Research grant (SBIR) in the United States.

The articles can also be a useful resource for other consultancies in the grant space as well as professional grant writers who are hired as freelancers or are part of a Small and Medium-sized Enterprise (SME). The EIC Accelerator is part of Horizon Europe (2021-2027) which has recently replaced the previous framework program Horizon 2020.

This article was written by ChatEIC. ChatEIC is an EIC Accelerator assistant that can advise on the writing of proposals, discuss current trends and create insightful articles on a variety of topics. The articles written by ChatEIC can contain inaccurate or outdated information.

- Contact Us -

 

EIC Accelerator Articles

All Eligible EIC Accelerator Countries (including the United Kingdom, Switzerland and Ukraine)

Explaining the Resubmission Process for the EIC Accelerator

A Short but Comprehensive Explanation of the EIC Accelerator

The EIC’s One-Stop Shop Funding Framework (Pathfinder, Transition, Accelerator)

Deciding Between EIC Pathfinder, Transition and Accelerator

A Winning Candidate for the EIC Accelerator

The Challenge with EIC Accelerator Open Calls: MedTech Innovations Dominate

Go Fund Yourself: Are EIC Accelerator Equity Investments Necessary? (Presenting Grant+)

EIC Accelerator DeepDive: Analyzing the Industries, Countries and Funding Types of EIC Accelerator Winners (2021-2024)

Digging Deep: The New DeepTech Focus of the EIC Accelerator and its Funding Bottlenecks

Zombie Innovation: EIC Accelerator Funding for the Living Dead

Smack My Pitch Up: Changing The Evaluation Focus Of The EIC Accelerator

How Deep Is Your Tech? The European Innovation Council Impact Report (EIC Accelerator)

Analyzing A Leaked EIC Accelerator Interview List (Success Rates, Industries, Direct Submissions)

Steering the EIC Accelerator: Lessons Learned from the Pilot Program

Who Should Not Apply To The EIC Accelerator And Why

The Risk of Presenting all Risks in the High-Risk EIC Accelerator Program

How to Prepare an EIC Accelerator Resubmission

How to Prepare a Good EIC Accelerator Application: General Project Advice

How to Craft an EIC Accelerator Rebuttal: Explaining Grant Proposal Resubmissions

 

Rasph - EIC Accelerator Consulting
en_US